Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05).
Conde-Moreno AJ, López-Campos F, Hervás A, Morillo V, Méndez A, Puertas MDM, Valero-Albarrán J, Gómez Iturriaga A, Rico M, Vázquez ML, Samper Ots PM, Perez-Romasanta LA, Pastor J, Ibáñez C, Ferrer F, Zapatero A, García-Blanco AS, Rodríguez A, Ferrer C. Conde-Moreno AJ, et al. Among authors: valero albarran j. Pract Radiat Oncol. 2024 Sep-Oct;14(5):e344-e352. doi: 10.1016/j.prro.2024.04.022. Epub 2024 Jun 29. Pract Radiat Oncol. 2024. PMID: 38944806 Clinical Trial.
Prospective study on stereotactic body radiotherapy for small pancreatic neuroendocrine tumors: tolerance and effectiveness analysis.
López Gonzalez M, Hernando-Requejo O, Ciervide Jurío R, Montero Luis Á, Saiz Guisasola C, Sánchez Saugar E, Álvarez Rodríguez B, Chen-Zhao X, García-Aranda M, Valero Albarran J, Alonso Gutierrez R, García Cañamaque L, Prados S, Quijano Y, de Vicente E, Rubio C. López Gonzalez M, et al. Among authors: valero albarran j. Clin Transl Oncol. 2025 Jan;27(1):377-385. doi: 10.1007/s12094-024-03538-w. Epub 2024 Jun 22. Clin Transl Oncol. 2025. PMID: 38907097
Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy.
Henríquez López I, González-San Segundo C, Vegas JO, Gutierrez C, Hervas A, Cabeza Rodriguez MÁ, Valero Albarrán J, Rodríguez Villalba S, Álvarez Gonzalez A, Sancho Pardo G, Zapatero A, Álvaro PC. Henríquez López I, et al. Among authors: valero albarran j. Radiother Oncol. 2019 Dec;141:156-163. doi: 10.1016/j.radonc.2019.09.006. Epub 2019 Sep 27. Radiother Oncol. 2019. PMID: 31570236